High Times
Home > Boards > Other Markets > Foreign Stock Markets >

BioInvent International AB (BINV.ST) (BINV.ST)

Add BINV.ST Price Alert      Hide Sticky   Hide Intro
Moderator: ancientacid
Search This Board: 
Last Post: 2/22/2017 8:10:04 AM - Followers: 1 - Board type: Free - Posts Today: 0


BioInvent is a research-based pharmaceutical company that focuses on developing antibody drugs against cancer. The Company's pipeline currently includes three product candidates for the treatment of cancer:
* BI-1206
* TB-403
* BI-505

The antibody library n-CoDeR and screening tool FIRST are two patented tools that enable the identification of relevant human antibodies and disease targets during the discovery phase. This platform is also utilized by partners who finance the development of new drugs which makes BioInvent entitled to milestone payments and royalties on sales. Such partners include Bayer HealthCare, Daiichi Sankyo, Mitsubishi Tanabe, Servier and XOMA.

BioInvent is traded on Stockholm Stock Exchange.
Ticker: BINV.ST
ISIN: SE0000789711

Market Cap (2016-01-01) SEK 617.46M ($73,15M)

Recent headlines

BioInvent Selected for Manufacturing Services by Global Pharmaceutical Company; Expects to Generate about SEK 25 Million in Revenue

BioInvent Update on Clinical and Preclinical Drug Programs

BioInvent in-Licenses Cutting Edge Technology to Pave the Way for More Efficacious Cancer Treatments

Q3 2015 BioInvent International AB Earnings Release

BioInvent Interim Report 1 January – 30 September 2015
High Times
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!